GENIXUS, Corp.
Reinventing injectable generic medicines into modern, easy to use, accessible formats for improved patient safety and medical efficiency.
- Stage Product In Development
- Industry Biotechnology
- Location Kannapolis, NC, USA
- Currency USD
- Founded February 2020
- Employees 5
- Incorporation Type C-corp
- Website genixus.com
Company Summary
Why are sterile injectable products not manufactured in a ready-to-use format? Why are these critical products often found on shortage lists or involved in quality issues and recalls?
To address these issues, our team, with over 50 years of combined clinical, manufacturing, quality, and commercial experience, reinvents them into modern, easy to use, accessible formats for improved patient safety and medical efficiency.
Team
-
CEO & Founder -
Chief Commercial Officer -
Martin KehellerChief Financial OfficerMartin spent 15 years in Europe in finance roles for FMCG. In the US he worked in senior roles for Nortel Networks and Monster.com (CFO). He has helped scale companies and create substantial value at Sonicbids.com, DiningIn.com , Brooks Bell and Kymanox. Martin is qualified as an accountant in the UK, is a FCMA, holds an MBA from The Fuqua School of Business at Duke University, and a B Commerce degree from University College Cork in Ireland
-
EVP, Global Head of Intellectual PropertyDon is an attorney focused on intellectual property and pharmaceutical law. Don has counselled clients on product development, litigation strategy, regulatory filings, commercial agreements and built strong patent and trademark portfolios. Don was previously SVP of IP at Mayne Pharma, holds a JD from Georgetown, a PhD in Chemical Physics from Michigan State University, and a Bachelor and Master of Science in Chemistry from Simon Fraser University
Advisors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.